Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sufentanil Sublingual Tablet System vs Oral Oxycodone for Postoperative Pain in TKA
NCT04448457Completed
- Sponsor
- CHU Tivoli
- Start
- Sep 2017
- Primary completion
- Jul 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of SurBred in postoperative pain (2 arms), sponsored by CHU Tivoli. Primary endpoint: Postoperative pain score at 24 hours. Started Sep 2017; status: completed.
02
Drugs
SurBred
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04448457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04448457.